Send a copy of "Kalamazoo firm developing new type 2 diabetes drugs gets $23.5 million for clinical trials" to a friend!
Your name:
Friend's name:
Your email:
Friend's email:
Anisyn, Inc.
Arcadia Supplements, LLC
Bioscience Research & Commercialization Center
CeeTox
Emiliem
Genemarkers
Metabolic Solutions Development Company
Micromyx
MLC Research and Development
NanoVir
ProNAi Therapeutics
PSB ADME Associates, LLC
RealBio Technology, Inc.
Single Source Procurement
Sunapten Therapeutics
Tetra Discovery Partners, LLC
Vestaron Corporation
West Labs Scientific